The device which weighs less than 3kg — the size of a small toaster — can also tell if someone is negative in as little as 13 minutes
With three units of this device, Nigeria can run more tests in one day than it had run in four weeks.
Abbott announced on Saturday that the US Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19).
According to the company, the test will run “on the company’s ID NOW™ platform, providing rapid results in a wide range of healthcare settings such as physicians’ offices, urgent care clinics and hospital emergency departments”.
The ID NOW is already the most widely available molecular point-of-care testing platform in the U.S. today.